ADC Therapeutics SA (ADCT) Earnings Date & Reports
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ADCT is expected to report earnings to rise 92.73% to -21 cents per share on November 10
Q3'26
Est.
$-0.21
Q2'26
Beat
by $0.11
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.20
Q3'25
Beat
by $0.17
The last earnings report on August 13 showed earnings per share of -10 cents, beating the estimate of -21 cents. With 1.09M shares outstanding, the current market capitalization sits at 127.23M.